Middle East and Asia Pacific Antibody Drugs Market Size Projected to Reach USD 175.72 Billion by 2032
The Middle East and Asia Pacific Antibody Drugs Market comprises the sales, distribution, and consumption of therapeutic antibodies, which are highly specific proteins designed to target disease-causing agents, such as cancer cells or inflammatory proteins. These drugs, primarily Monoclonal Antibodies (mAbs), are central to the field of targeted therapy and are increasingly replacing...
0 Комментарии 0 Поделились 37 Просмотры 0 предпросмотр
MTSocial https://mtsocial.ir